Back to Dashboard








Agilent Technologies, Inc. (A)
Real-time intraday values
Market Overview
From:
To:
A Intraday
No data available
SymbolA
IPO DateNov 18, 1999
CEOMr. Padraig McDonnell
Full Time Employees18.2k
SectorHealthcare
IndustryDiagnostics & Research
CountryUnited States
ExchangeNYSE
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Performance
| Period | Return % | Value Change |
|---|---|---|
| 1 Day | -0.51% | -0.88 US$ |
| 5 Days | +0.02% | +0.04 US$ |
| 1 Month | +4.65% | +7.69 US$ |
| 6 Months | +49.73% | +57.46 US$ |
Analyzing Market with AI
Evaluating the last 30 days of history and fundamental metrics of A...
Key Statistics
Market Cap
48.80B
P/E Ratio
34.14
Div Yield
0.59%
52W High
$179.10
52W Low
$108.35
Analyst Consensus
ConsensusBuy
Bullish1466.7%
Neutral733.3%
Bearish00.0%
52W Analyst Price Targets
Min Target
$155.00
$155.00
Max Target
$200.00
$200.00
Current$173.01
Avg Target$181.63
Analyst Recommendations
Target Price:$181.63($155.00 - $200.00)
Community Thoughts
Share your analysis and sentiment on A
Join the community to share your analysis
Latest News for A

Should Illumina Stock Holders Look At Thermo Fisher Instead?
Trefis•Oct 23, 2026, 05:36 PM

DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market
Zacks•Oct 22, 2026, 05:17 PM

ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up
Zacks•Oct 21, 2026, 12:29 PM


Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows
Zacks•Oct 20, 2026, 01:20 PM
First Trust Capital Strength (FTCS) Buys $155.3 Million More ACGL on Friday
GuruFocus.com•Oct 20, 2026, 11:03 AM
29 ETFs Add to Agilent Technologies (A) on Oct. 16
GuruFocus.com•Oct 20, 2026, 11:00 AM

1 Surging Healthcare Stock Worth Your Attention and 2 We Turn Down
StockStory•Oct 16, 2026, 02:11 PM

Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests
GlobeNewswire•Oct 16, 2026, 09:43 AM